From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

Lung cancer may be curable, depending on a number of factors, including your age, health, stage of cancer, and how it ...

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

The age-adjusted cancer death rate has fallen since the 1990s, with the world winning the so-called "war on cancer." ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

They want to gain a deeper understanding of why the disease behaves differently in these patients. Read more at ...

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, ...

Promising efficacy data with median PFS of 7.2 months (95%CI 5.6-9.2), median OS of 13.7 months (95%CI 11.1-18.3), and 1-year survival of 54% Strong efficacy signal observed in non-squamous ...

Study compared use of chemotherapy and radiotherapy in 280,000 people from Britain, Australia, Norway and Canada ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Small cell lung cancer (SCLC), one of the deadliest types of lung cancer, is an aggressive tumor that metastasizes early ...